CVE-2023-26979

LOWCVSS 3.1/10EPSS 0.18%

Last modified

CVE-2023-26979 is a low-severity vulnerability rated 3.1/10 on the CVSS scale. Bluetens Electrostimulation Device BluetensQ device app version 4.3.15 is vulnerable to Man-in-the-middle attacks in the BLE channel. It allows attackers to decrease or increase the intensity of the stimulator by hijacking the BLE communication.. EPSS estimates a 0.18% chance of exploitation in the next 30 days.

Description

Bluetens Electrostimulation Device BluetensQ device app version 4.3.15 is vulnerable to Man-in-the-middle attacks in the BLE channel. It allows attackers to decrease or increase the intensity of the stimulator by hijacking the BLE communication.

Metrics

CVSS 3.1
3.1/10

CVSS:3.1/AV:A/AC:H/PR:N/UI:N/S:U/C:N/I:L/A:N

EPSS Probability
0.18%

7.9th percentile

Probability of exploitation in the next 30 days. Learn more

Weakness Enumeration

Affected Software

VendorProductVersions
BluetensBluetensq4.3.15

References

Timeline

Published
Last Modified
Status
Modified

Frequently Asked Questions

What is CVE-2023-26979?
Bluetens Electrostimulation Device BluetensQ device app version 4.3.15 is vulnerable to Man-in-the-middle attacks in the BLE channel. It allows attackers to decrease or increase the intensity of the stimulator by hijacking the BLE communication.
How severe is CVE-2023-26979?
CVE-2023-26979 has a CVSS score of 3.1/10 (LOW severity). The EPSS model estimates a 0.18% probability of exploitation in the next 30 days.
How do I fix CVE-2023-26979?
Check the vendor references and advisories linked above for patched versions and mitigation guidance. You can also run a Strix scan to test if your systems are affected.

Are you affected by CVE-2023-26979?

Run a free Strix scan to check your systems for this vulnerability.

Scan your code now

Source: NVD / NIST